Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04746833 · ClinicalTrials.gov registry record · NA
Development/Testing of SUMMIT: a Tool to Help Patients Manage Pain While Tapering Opioids
A NA study of Chronic Pain, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 4
- Study locations
NCT04746833 is a NA study of Chronic Pain that has completed, run by VA Office of Research and Development. The registered enrollment target is 44 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (94% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT04746833, a NA study of Chronic Pain, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 4
- Study locations
Study Summary
There are nearly one million veterans being treated with long-term opioid therapy (LTOT) for chronic pain. Numerous short and long-term harms associated with LTOT and mounting evidence suggest they have modest or no benefit. Yet, currently available resources to support veterans to taper are inadequate. Primary care, where most LTOT in VHA is prescribed, is overburdened and straining to meet the challenge of caring for patients with chronic pain. A scalable, relatively inexpensive tapering intervention to support primary care and/or to extend the reach of resource-intensive specialty clinics would be of great benefit to veterans who are not deriving sufficient benefit from LTOT. As such, the goal of this study is to develop and test an interactive, theory-informed, multi-component mobile website to enable veterans to safely taper opioids while managing their pain.
Conditions Studied
Interventions
- BEHAVIORAL control
- BEHAVIORAL SUMMIT
Study Locations (4)
Connecticut
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT - West Haven
Massachusetts
- VA Central Western Massachusetts Healthcare System, Leeds, MA - Leeds
Pennsylvania
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA - Philadelphia
Utah
- VA Salt Lake City Health Care System, Salt Lake City, UT - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2021-03-24 |
| Est. Completion | 2023-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04746833
The ClinicalTrials.gov registry entry for NCT04746833 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (94% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which control is the first listed.
NCT04746833 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Connecticut, Massachusetts, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04746833 about?
NCT04746833 is a clinical study titled "Development/Testing of SUMMIT: a Tool to Help Patients Manage Pain While Tapering Opioids". There are nearly one million veterans being treated with long-term opioid therapy (LTOT) for chronic pain. Numerous short and long-term harms associated with LTOT and mounting evidence suggest they have modest or no benefit. Yet, currently available resources to support veterans to taper are inadequ...
What is the current status of trial NCT04746833?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2021-03-24. Estimated completion is 2023-11-30.
What conditions does trial NCT04746833 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT04746833?
The interventions under investigation include: control (BEHAVIORAL), SUMMIT (BEHAVIORAL).
Who is sponsoring clinical trial NCT04746833?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04746833 being conducted?
This trial has 4 study locations across Connecticut, Massachusetts, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.